Urology CompaniesU.S. Exchanges
List of Publicly Traded Urology Companies Listed on Major U.S. Exchanges
The publicly traded companies on this list are biotech, medical device, pharmaceutical or other healthcare companies that provide products relating to urology. It is very common for companies on this list to provide products and services in other healthcare areas in addition to urology.
Additional publicly traded healthcare companies and healthcare categories can be accessed through the link below:
A comparison widget that shows trend, earnings per share (EPS), P/E ratio and beta for each of the companies on this list can be accessed through the link below.
Select the company’s link to access charts, news links and company website and social media information.
Urology: Large-Cap Stocks
Boston Scientific Corporation (BSX) (Areas of focus include digestive, heart, pulmonary, urological, vascular and women’s health)
C.R. Bard, Inc. (BCR) (Oncology, surgical specialty, urology and vascular products)
Urology: Mid-Cap Stocks
Teleflex Incorporated (TFX) (Single-use medical devices used in diagnostic and therapeutic procedures: anesthesia, cardiac care, EMS, interventional access, urology, vascular access)
Urology: Micro-Cap Stocks
Cogentix Medical, Inc. (CGNT) (Medical devices: urology and airway management)
EDAP TMS S.A. (EDAP) (Minimally invasive medical devices used primarily for urological diseases)
Nymox Pharmaceutical Corporation (NYMX) (Drugs and diagnostic products for the aging population; treatment for enlarged prostate or benign prostatic hyperplasia)
Sophiris Bio, Inc. (SPHS) (Biopharmaceutical company: urological diseases)
UroGen Pharma Ltd. (URGN) (IPO May 4, 2017; biopharmaceutical company: urological conditions)
Urology: Nano-Cap Stocks
Apricus Biosciences, Inc. (APRI) (Biopharmaceutical company: sexual health therapies, urology and rheumatology)
Imprimis Pharmaceuticals, Inc. (IMMY) (Ophthalmology and urology drug therapies)